Donald Trump

Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData

Read more

China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024

Read more

US drug pricing order – Implications for India’s pharma sector

Read more

Trump calls for drug price cuts, order aims to reduce prices by 30-80 per cent

Read more

Trumping the Budget blues?

Read more

Pharmapack outlines pharma trends 2025, highlights market optimism despite uncertainty

Read more

Donald Trump’s return sparks uncertainty for US pharma and healthcare industries: GlobalData

Read more

US Congress approves $892 bn COVID-19 relief package billion

Read more

US, AstraZeneca sign pact for COVID-19 antibody treatment used to treat Trump

Read more

Working with India on COVID-19 vaccine development: US President

Read more